Project Grant CLSS00000062630

The federal Project Grant award with ID DP2DA062283 was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The $2,542,500 grant, awarded on September 1, 2024, will support the development of novel econometric methods and a unified framework for integrating real-world evidence (RWE) to analyze inconclusive randomized controlled trials (RCTs) focused on opioid use disorder (OUD) treatments. The project, to be conducted by Weill...

Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a Project Grant of $198,164 to the University of Pittsburgh under the Drug Use and Addiction Research Programs (CFDA 93.279) on September 25, 2025, with a completion date of April 30, 2028. The grant funds research investigating Delta Opioid Receptor (DOR) regulation of parvalbumin interneuron transmission and oxycodone-related behavior in the context of opioid use disorder (OUD). The research addresses a critical...

Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded University of Colorado-Denver a Project Grant of $709,085 under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct an implementation trial examining in-hospital opioid treatment program (OTP) intake facilitation. The project, awarded April 1, 2026 with a completion date of January 31, 2031, will implement a series of evidence-based implementation facilitation activities across four hospitals to...

Federal Grant Award Summary The Naloxone Project (TNP) received a $600,000 project grant from the Federal Office of Rural Health Policy under the Rural Healthcare Services Programs (CFDA 93.912) effective September 1, 2025, through August 31, 2026. The Colorado Coalition for Harm Reduction, Access to Naloxone, and Grassroots Rural Engagement (Colorado CHANGE) project addresses the opioid overdose crisis in Colorado's rural communities, where overdose death rates exceed state averages. TNP will...

Federal Grant Award Summary Oregon Health & Science University (OHSU) received a $453,062 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning September 1, 2025, and extending through May 31, 2030. The grant funds research investigating the cellular mechanisms of opioid tolerance through studies of mu opioid receptor (MOR) trafficking and endosomal recycling. The research employs proteomic and genomic...

Federal Grant Award Summary Louisiana State University Health Sciences Center New Orleans received a $225,065 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective August 15, 2025, with a completion date of July 31, 2027. The award supports research on targeting the renin system as a novel therapeutic approach for managing chronic pain and opioid use disorder (OUD). The project leverages the FDA-approved...

Federal Grant Award Summary Drexel University received a $832,132 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded on March 1, 2026, with a completion date of February 29, 2028. This research project investigates novel neurobiological mechanisms underlying opioid-induced dopamine elevation in the nucleus accumbens, advancing scientific understanding of opioid use disorder—a critical public health crisis....

Federal Grant Award Summary Boston Medical Center Corporation received a $2.67 million Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded May 1, 2026, for a four-year project period concluding April 30, 2030. The award funds development and implementation of LINK, a system-wide intervention designed to optimize utilization of medications for opioid use disorder (MOUD) and pre-exposure prophylaxis for HIV (PrEP)...

Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded $450,175 under the Drug Use and Addiction Research Programs (CFDA 93.279) to the Research Foundation For Mental Hygiene, Inc., through its New York State Psychiatric Institute division, to conduct a clinical research study investigating the efficacy of sphenopalatine ganglion (SPG) nerve blocks as an adjunctive treatment for opioid use disorder (OUD). The award, effective May 15, 2026, through April 30, 2028, funds...

Opos.ai, Inc. received a $267,557 Project Grant award from the National Science Foundation on December 1, 2021 to develop an opioid taper clinical decision support tool for use in primary care outpatient settings. The tool will assist primary care providers in safely tapering patients off opioid medications and is intended to address the ongoing public health crisis of opioid addiction and overdose. This award falls under the NSF's Technology, Innovation, and Partnerships program (CFDA...